{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:12:31Z","timestamp":1788797551814,"version":"build-2803163510"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      The aim of the study was to detect the expression level of thymosin \u03b24 (T\u03b24) in serum and tissues of patients with chronic hepatitis B (CHB) combined nonalcoholic fatty liver disease (NAFLD). The effects of T\u03b24 in hepatic steatosis, chronic inflammation, and fibrosis development in CHB combined NAFLD patients were also discussed. The study included 46 patients in the case group with CHB and NAFLD and 42 patients in the control group with CHB. ELISA was applied to detect serum T\u03b24 and TNF-\u03b1 level. Furthermore, the correlation analysis of T\u03b24 levels with biochemical index, pathological index, and TNF-\u03b1 level was performed. The T\u03b24 immunohistochemical levels of different inflammation fibrosis levels were compared, and the correlation analysis with TNF expression was performed. The T\u03b24 levels in patients with CHB combined NAFLD showed no statistical difference when compared to the control group. In patients with CHB combined NAFLD group, the T\u03b24 level had no correlation with ALT, AST, TG, FGP, hepatitis B virus (HBV)-DNA levels, and fat grading, but had negative correlation with inflammation score and fibrosis score (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.01). The immunohistochemical results of hepatic tissues showed that the expression intensity of severe inflammation fibrosis group had statistical significance compared with that of slight group, and the T\u03b24 expression both in serum and in liver tissue negatively correlated with TNF-\u03b1 expression. T\u03b24 could be involved in the regulation of chronic inflammation and fibrosis and plays a defense role in the disease progression of CHB combined NAFLD patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000005763","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T14:06:09Z","timestamp":1483020369000},"page":"e5763","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["The expression of thymosin \u03b24 in chronic hepatitis B combined nonalcoholic fatty liver disease"],"prefix":"10.1097","volume":"95","author":[{"given":"Jing","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingtang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-52-20260907","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1254\/jphs.09234FP","article-title":"Hepatoprotective effect of pinoresinol on carbon tetrachloride-induced hepatic damage in mice","volume":"112","author":"Kim","year":"2010","journal-title":"J Pharmacol Sci"},{"key":"R2-52-20260907","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1478-3231.2007.01482.x","article-title":"Impact of non-alcoholic fatty liver disease on chronic hepatitis B","volume":"27","author":"Bondini","year":"2007","journal-title":"Liver Int"},{"key":"R3-52-20260907","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1440-1746.2008.05361.x","article-title":"Hepatitis B and fatty liver: causal or coincidental?","volume":"23","author":"Fan","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"R4-52-20260907","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3349\/ymj.2016.57.4.885","article-title":"The relationship between type 2 diabetes mellitus and non-alcoholic fatty liver disease measured by controlled attenuation parameter","volume":"57","author":"Chon","year":"2016","journal-title":"Yonsei Med J"},{"key":"R5-52-20260907","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2337\/dc10-2229","article-title":"Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study","volume":"34","author":"Williamson","year":"2011","journal-title":"Diabetes Care"},{"key":"R6-52-20260907","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1517\/14712598.2015.1011617","article-title":"Advances in the basic and clinical applications of thymosin beta4","volume":"15","author":"Goldstein","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"R7-52-20260907","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1096\/fj.03-0121fje","article-title":"The actin binding site on thymosin beta4 promotes angiogenesis","volume":"17","author":"Philp","year":"2003","journal-title":"FASEB J"},{"key":"R8-52-20260907","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1749-6632.2012.06693.x","article-title":"Molecular and cellular mechanisms of thymosin beta4-mediated cardioprotection","volume":"1269","author":"Hinkel","year":"2012","journal-title":"Ann NY Acad Sci"},{"key":"R9-52-20260907","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.2012.06713.x","article-title":"Thymosin beta4 mobilizes mesothelial cells for blood vessel repair","volume":"1269","author":"Shelton","year":"2012","journal-title":"Ann NY Acad Sci"},{"key":"R10-52-20260907","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbrc.2014.09.012","article-title":"Thymosin beta4 induces invasion and migration of human colorectal cancer cells through the ILK\/AKT\/beta-catenin signaling pathway","volume":"452","author":"Piao","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"R11-52-20260907","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3748\/wjg.v16.i5.625","article-title":"Serum thymosin beta4 levels in patients with hepatitis B virus-related liver failure","volume":"16","author":"Han","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R12-52-20260907","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.clinre.2014.02.004","article-title":"Thymosin beta 4: a novel assessed biomarker of the prognosis of acute-on-chronic liver failure patient?","volume":"38","author":"Liu","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R13-52-20260907","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12072-014-9526-8","article-title":"Novel modulators of hepatosteatosis, inflammation and fibrogenesis","volume":"8","author":"Lakshman","year":"2014","journal-title":"Hepatol Int"},{"key":"R14-52-20260907","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/jmv.22048","article-title":"High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe","volume":"83","author":"Gobel","year":"2011","journal-title":"J Med Virol"},{"key":"R15-52-20260907","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"R16-52-20260907","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.4254\/wjh.v7.i10.1337","article-title":"Liver steatosis in hepatitis C patients","volume":"7","author":"Gonzalez-Reimers","year":"2015","journal-title":"World J Hepatol"},{"key":"R17-52-20260907","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1053\/j.gastro.2007.03.039","article-title":"Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPAR gamma","volume":"132","author":"Kim","year":"2007","journal-title":"Gastroenterology"},{"key":"R18-52-20260907","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3748\/wjg.v11.i20.3056","article-title":"Viral and host causes of fatty liver in chronic hepatitis B","volume":"11","author":"Altlparmak","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R19-52-20260907","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7150\/ijms.5649","article-title":"Clinical and virological characteristics of chronic hepatitis B patients with hepatic steatosis","volume":"10","author":"Zheng","year":"2013","journal-title":"Int J Med Sci"},{"key":"R20-52-20260907","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.atherosclerosis.2015.01.001","article-title":"A concise review of non-alcoholic fatty liver disease","volume":"239","author":"Than","year":"2015","journal-title":"Atherosclerosis"},{"key":"R21-52-20260907","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"R22-52-20260907","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3109\/10715762.2015.1078461","article-title":"Endoplasmic reticulum stress and oxidative stress in the pathogenesis of non-alcoholic fatty liver disease","volume":"49","author":"Ashraf","year":"2015","journal-title":"Free Radic Res"},{"key":"R23-52-20260907","doi-asserted-by":"crossref","first-page":"e26912","DOI":"10.1371\/journal.pone.0026912","article-title":"Thymosin beta 4 prevents oxidative stress by targeting antioxidant and anti-apoptotic genes in cardiac fibroblasts","volume":"6","author":"Kumar","year":"2011","journal-title":"PLoS One"},{"key":"R24-52-20260907","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/1756283X11413002","article-title":"Current status of novel antifibrotic therapies in patients with chronic liver disease","volume":"4","author":"Cohen-Naftaly","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"R25-52-20260907","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/MCG.0000000000000544","article-title":"Histologic disease in Chinese chronic hepatitis B patients with low viral loads and persistently normal alanine aminotransferase levels","volume":"50","author":"Wang","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"R26-52-20260907","doi-asserted-by":"crossref","first-page":"e10640","DOI":"10.5812\/hepatmon.10640","article-title":"Normal limit for serum alanine aminotransferase level and distribution of metabolic factors in old population of Kalaleh, Iran","volume":"13","author":"Kabir","year":"2013","journal-title":"Hepat Mon"},{"key":"R27-52-20260907","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1111\/j.1582-4934.2010.01204.x","article-title":"From proteomic multimarker profiling to interesting proteins: thymosin-beta 4 and kininogen-1 as new potential biomarkers for inflammatory hepatic lesions","volume":"15","author":"Henkel","year":"2011","journal-title":"J Cell Mol Med"},{"key":"R28-52-20260907","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/bjo.2007.136747","article-title":"Thymosin beta-4 upregulates anti-oxidative enzymes and protects human cornea epithelial cells against oxidative damage","volume":"92","author":"Ho","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R29-52-20260907","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1111\/liv.12523","article-title":"Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?","volume":"34","author":"Tariq","year":"2014","journal-title":"Liver Int"},{"key":"R30-52-20260907","doi-asserted-by":"crossref","first-page":"379","DOI":"10.31083\/ph.2014.3805","article-title":"Necrosis factor-alpha (TNF-alpha) response in human hepatoma HepG2 cells treated with hepatotoxic agents","volume":"69","author":"Xie","year":"2014","journal-title":"Pharmazie"},{"key":"R31-52-20260907","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1096\/fj.10-167940","article-title":"Thymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK","volume":"25","author":"Qiu","year":"2011","journal-title":"FASEB J"},{"key":"R32-52-20260907","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/gut.2008.157735","article-title":"Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B","volume":"58","author":"Wong","year":"2009","journal-title":"Gut"},{"key":"R33-52-20260907","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1440-1746.2008.05531.x","article-title":"Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection","volume":"23","author":"Shi","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"R34-52-20260907","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"R35-52-20260907","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.4081\/ejh.2011.e25","article-title":"Expression pattern of thymosin beta 4 in the adult human liver","volume":"55","author":"Nemolato","year":"2011","journal-title":"Eur J Histochem"},{"key":"R36-52-20260907","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000363005","article-title":"Depletion of thymosin beta4 promotes the proliferation, migration, and activation of human hepatic stellate cells","volume":"34","author":"Xiao","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"R37-52-20260907","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1196\/annals.1415.035","article-title":"Thymosin beta4 upregulates the expression of hepatocyte growth factor and downregulates the expression of PDGF-beta receptor in human hepatic stellate cells","volume":"1112","author":"Barnaeva","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R38-52-20260907","doi-asserted-by":"crossref","first-page":"10624","DOI":"10.3390\/ijms160510624","article-title":"Potential role of thymosin Beta 4 in liver fibrosis","volume":"16","author":"Kim","year":"2015","journal-title":"Int J Mol Sci"},{"key":"R39-52-20260907","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11894-014-0372-6","article-title":"Utilization of FibroScan in clinical practice","volume":"16","author":"Bonder","year":"2014","journal-title":"Curr Gastroenterol Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005792-201612300-00052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:03:54Z","timestamp":1788797034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201612300-00052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":39,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005763","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}